KRAS and ovarian carcinoma: Many gene abnormalities have been detected in ovarian cancers, for example, the overexpression of c-erbB-2, mutation of Ki-ras, p53, BRCA1 or BRCA2, and the expression of telomerase activity (Matias-Guiu and Prat, 1998).